Background
In this single-institution case-control study, we identified risk factors associated with inflammatory breast cancer (IBC) subtypes based on staining of (estrogen receptor [ER], progesterone receptor [PR]) and expression of human epidermal growth factor 2 (HER2neu) to determine distinct etiologic pathways.
Methods
We identified 224 women with IBC and 396 cancer-free women seen at the MD Anderson Cancer Center. Multinomial logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations between breast cancer risk factors and the IBC tumor subtypes: luminal (ER+ and/or PR+/Her2neu−), Her2neu+ (any ER and PR, Her2neu+), and triple-negative (ER−/PR−/Her2neu−).
Results
In multivariable analysis, compared with women age ≥ 26 at first pregnancy, women age <26 had a higher risk of triple-negative IBC (OR 3.32, 95% CI 1.37–8.05). Women with a history of breastfeeding had a lower risk of triple-negative (OR 0.30; 95% CI: 0.15–0.62) and luminal IBC (OR 0.35, 95% CI 0.18–0.68). A history of smoking was associated with an increased risk of luminal IBC (OR 2.37; 95% CI 1.24–4.52). Compared with normal-weight women, those who were overweight or obese (body mass index ≥25 kg/m2) had a higher risk of all three tumor subtypes (P<0.01 for all subtypes).
Conclusion
Overweight or obese status are important modifiable risk factors for IBC of any subtype. Modifiable risk factors, age at first pregnancy (≥26), breastfeeding and smoking may be associated with specific IBC subtypes. These results highlight the importance of evaluating epidemiologic risk factors for IBC for the identification of subtype-specific prevention strategies.